| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/26/2003 | EP1284720A2 Method of treating hepatitis delta viral infection |
| 02/26/2003 | EP1284719A2 The use of a calcium channel blocker for treating renal disorders |
| 02/26/2003 | EP1284717A1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 02/26/2003 | EP1284711A1 Blister package for topiramate tablets |
| 02/26/2003 | EP1284653A2 Infrared thermography and methods of use |
| 02/26/2003 | EP1284601A2 Allantoin-containing skin cream |
| 02/26/2003 | EP1237563A4 Nutritional composition, methods of producing said composition and methods of using said composition |
| 02/26/2003 | EP1212453A4 Method to identify gene function using small molecule probes |
| 02/26/2003 | EP1169019B1 Pharmaceutical aerosol formulation |
| 02/26/2003 | EP1150976B1 3-(thio-substituted amido)-lactams useful as inhibitors of matrix metalloproteinase |
| 02/26/2003 | EP1143952B1 Method and composition for treating and preventing tuberculosis |
| 02/26/2003 | EP1119539B1 A process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds |
| 02/26/2003 | EP1100797B1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 02/26/2003 | EP1052998A4 Compositions and methods for modulating cytokine release in response to genotoxic agents |
| 02/26/2003 | EP1042324B1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof |
| 02/26/2003 | EP1042297B1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 02/26/2003 | EP1032386B1 Use of oxazolidinone derivatives for treating arthritis |
| 02/26/2003 | EP1011726B1 Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents |
| 02/26/2003 | EP1003903B1 Process for preparing enantiomerically enriched n-derivatised lactams |
| 02/26/2003 | EP0971901B1 Phthalazinones |
| 02/26/2003 | EP0969827B1 Mixture of primary fatty acids obtained from sugar cane wax |
| 02/26/2003 | EP0941221B1 Substituted dihydrobenzofurans as pde inhibitors |
| 02/26/2003 | EP0938483B1 Muscarinic antagonists |
| 02/26/2003 | EP0934304B1 2-pyrimidineamine derivatives and processes for their preparation |
| 02/26/2003 | EP0929571B1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 02/26/2003 | EP0920431B1 Thienopyrimidines |
| 02/26/2003 | EP0876348B1 Salts of quinoline derivatives as nk3 antagonists |
| 02/26/2003 | EP0850059B1 Pharmaceutical formulations containing darifenacin |
| 02/26/2003 | EP0832068B1 Stable reagents for the preparation of radiopharmaceuticals |
| 02/26/2003 | EP0824535B1 Antibacterial cephalosporins |
| 02/26/2003 | EP0798295B1 Novel amidinonaphthyl derivative or salt thereof |
| 02/26/2003 | EP0797448B1 Combination preparation, containing cyclosporin a or fk506 or rapamycin and a xanthine derivative |
| 02/26/2003 | EP0754040B1 Rapamycin derivatives |
| 02/26/2003 | EP0708763B1 Process for making hiv protease inhibitors |
| 02/26/2003 | EP0674621B1 Enantiomers of carbazole derivatives as 5-ht1-like agonists |
| 02/26/2003 | EP0655914B1 Use of Histamine-2 agonists for treatment of sexual dysfunction |
| 02/26/2003 | CN1399679A Altering gene expression with ssDNA produced in vivo |
| 02/26/2003 | CN1399644A Novel human G-Protein coupled receptor |
| 02/26/2003 | CN1399642A Method of preparing clarithromycin |
| 02/26/2003 | CN1399639A New oxabispidine compound useful in treatment of cardiac arrhythmias |
| 02/26/2003 | CN1399638A Indoloazepines as vasopressin receptor antagonists |
| 02/26/2003 | CN1399637A Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine and its prep. |
| 02/26/2003 | CN1399636A Adenosine receptor antagonists and methods of making and using the same |
| 02/26/2003 | CN1399635A Piperazing derivatives as 5-HT1B antagonists |
| 02/26/2003 | CN1399634A Hydroxyalkanoyl aminolactams and related structure as inhibitors of A beta protein production |
| 02/26/2003 | CN1399633A 嘧啶衍生物 Pyrimidine derivatives |
| 02/26/2003 | CN1399631A Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 02/26/2003 | CN1399630A Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 02/26/2003 | CN1399627A Method of preparing substituted tetracyclines with transition metal-based chemistries |
| 02/26/2003 | CN1399626A Ethers of o-desmethyl venlafaxine |
| 02/26/2003 | CN1399622A Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 02/26/2003 | CN1399573A Use of phthalazine derivatives |
| 02/26/2003 | CN1399572A Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| 02/26/2003 | CN1399565A Propellant free spray-on skin patch composition for improving wound healing and for drug administration |
| 02/26/2003 | CN1399561A Conjugate having cleavable linkage for use in liposome |
| 02/26/2003 | CN1399558A Treatment of viral infections |
| 02/26/2003 | CN1399552A Method and composition for treatment of adenoviral ocular infections |
| 02/26/2003 | CN1399551A Pernasal preparation |
| 02/26/2003 | CN1399550A Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats |
| 02/26/2003 | CN1399549A Ultrafinel-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 02/26/2003 | CN1399548A Composition for treatment of external secretion disorders |
| 02/26/2003 | CN1399546A Injectable preparation for controlling fish live comprising benzoyl urea derivatives |
| 02/26/2003 | CN1399545A Treatment of certain cancers associated with weight gain |
| 02/26/2003 | CN1399544A Multilayer preparation for controlled, pulsed release of active substances |
| 02/26/2003 | CN1399543A Controlled release composition comprising nimesulide |
| 02/26/2003 | CN1399540A Aerosol composition comprising formoterol |
| 02/26/2003 | CN1399533A Improved transdermal contraceptive delivery system and process |
| 02/26/2003 | CN1399520A Phytosterol and phytostanol compositions |
| 02/26/2003 | CN1399516A Novel composition |
| 02/26/2003 | CN1398966A Acidophilic thermostable mycose-base synthetase and its prepn and use |
| 02/26/2003 | CN1398873A Dinucleotide for treating pulmonary tuberulosis |
| 02/26/2003 | CN1398869A Process of extracting tannic acid from Geranium wilfordii root and the use of the extractive |
| 02/26/2003 | CN1398863A Benzo [b] pyran-[3,2-h] acridinyl-7-one compounds, their prepn and medicine composition containing them |
| 02/26/2003 | CN1398861A Prepn and application in preparing medicine of Fraxinus general coumarin |
| 02/26/2003 | CN1398854A New iso quinoline compound with HIV-1 resisting activity |
| 02/26/2003 | CN1398838A Diphenylethylene compound and its prepn and application in preventing and treating diabetes |
| 02/26/2003 | CN1398630A Active largehead atractylodes saccharide complex for reducing blood sugar and its prepn and use |
| 02/26/2003 | CN1398628A Itch-stopping bactericidal medicine and its prepn |
| 02/26/2003 | CN1398627A Chinese herbal medicine tumor-eliminating drop and its recipe |
| 02/26/2003 | CN1398623A Medicine for treating dermatosis and its prepn |
| 02/26/2003 | CN1398611A Chinese herbal medicine composition for treating caries pain and its prepn |
| 02/26/2003 | CN1398603A Plaster for treating pain in neck, shoulder, waist and leg and its prepn process |
| 02/26/2003 | CN1398593A Tumor cell growth inhibitor and its prepn process |
| 02/26/2003 | CN1398592A Medicine composition for treating tumor and cardiac and cerebral vascular diseases |
| 02/26/2003 | CN1398591A Anticancer cantharidoid-glycosamine coupler and its prepn and application |
| 02/26/2003 | CN1398590A Recipe and prepn of progesterone capsule |
| 02/26/2003 | CN1398589A Medicinal use and prepn process of general ketosteroid of Tinospora Hainanesis |
| 02/26/2003 | CN1398588A Application of arecaline hydrobromide as medicine for arrhythmia |
| 02/26/2003 | CN1398587A Slow-releasing Metronidazole prepn for position of colon |
| 02/26/2003 | CN1398586A New substituted heptoic acid derivative for treating bronchial asthma and chronic obstructive pulmonary tuberculosis |
| 02/26/2003 | CN1398582A Local acne treating device |
| 02/26/2003 | CN1102174C Ribozyme |
| 02/26/2003 | CN1102149C 4-haloalkyl-3-heterocycolyl pyridines and 4-haloalkyl-5-heterocyclylpyridines, method for producing same, composition containing same and use thereof |
| 02/26/2003 | CN1102145C Process for prepn. of N,N-substituted ureas |
| 02/26/2003 | CN1102144C Noval pyrimidine derivatives and prepn. processes thereof |
| 02/26/2003 | CN1102056C Plant night cream for treating pustular acne |
| 02/26/2003 | CN1102047C Reversing agent for multi-medicine resistance of tumor cells |
| 02/26/2003 | CN1102046C Oral antibacterial composition |
| 02/26/2003 | CA2420656A1 Antisense oligonucleotides against vanilloid receptor 1 |
| 02/25/2003 | WO2002026233A1 Infusion of ciprofloxacin having reduced acid content and being stable in storage |